Using the Case Study of Atezolizumab Development to Rethink Early Phase Oncology Trial Design

Frontiers in Biostatistics Seminar Tuesday February 14, 2023 1:00PM Eastern Time Hybrid format; register at https://bit.ly/FIBFeb23 Emily Zabor, DrPH Assistant Staff Biostatistician Department of Quantitative Health Sciences at the Cleveland Clinic, with a joint appointment in the Taussig Cancer Institute Assistant Professor of Medicine, the Cleveland Clinic Lerner College of Medicine of Case Western Reserve […]